Buy the BPC-157 and TB-500 Recovery Stack in Australia
Buy the BPC-157 and TB-500 recovery stack in Australia from Macropus Peptides: one priced listing that ships two sealed vials, BPC-157 in one and TB-500 in the other. Keeping the peptides apart lets a laboratory make up each to its own concentration, run single-compound control arms and record two independent lot numbers, something a premixed vial cannot offer. Both arrive as dry lyophilised powder under crimped caps, labelled with compound, strength, lot and storage temperature, and a certificate of analysis can be requested for each lot. The recovery stack suits groups comparing the two repair-related peptides side by side, while the single-vial blend remains the simpler choice for fixed-ratio work. Add bacteriostatic water to the same order, since the stack is supplied without diluent. Parcels are packed in Australia and sent to any Australian address. Sold to buyers aged 18 and over for in-vitro laboratory research only, not for human or veterinary use.
| Kit | Recovery stack BPC-157 + TB-500 |
|---|---|
| Amount | stack |
| Form | Research kit |
| Contents | BPC-157 and TB-500 in separate vials |
| Category | Kits, stacks and value packs |
| Storage | See label |
| Testing | HPLC purity 98% or higher and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
Buy the Recovery Stack Australia: BPC-157 and TB-500 Vials
Macropus Peptides sells the recovery stack as one listing that ships two sealed vials: BPC-157 in one and TB-500 in the other. Each peptide is lyophilised on its own, filled under its own lot number and backed by its own certificate of analysis. The order, the parcel and the paperwork stay together, while every later decision about water volume, storage and timing can be made separately for each compound.
What is in the BPC-157 and TB-500 stack
- One BPC-157 10mg vial, freeze-dried
- One TB-500 10mg vial, freeze-dried
- Two labels with compound, strength, lot and storage temperature
BPC-157 is a synthetic pentadecapeptide, fifteen amino acids long, copied from part of BPC, a body protection compound first isolated from gastric juice. It is unusually stable for a short peptide and stays intact in acidic conditions that break most chains apart. TB-500 is a synthetic peptide modelled on thymosin beta-4, a 43 residue protein present in almost every mammalian cell, and in particular on the short stretch that binds actin. Neither is an approved medicine anywhere, and both remain preclinical research compounds.
How the recovery stack peptides work in research
The two compounds are studied at different levels of the same repair process, which is the main reason laboratories order them together. BPC-157 work concentrates on signalling between cells: in cultured endothelial cells it has been tied to switching on VEGFR2, the main receptor for vascular endothelial growth factor, and in tendon fibroblasts to the FAK and paxillin pathway that controls how cells attach and spread. TB-500 acts inside the cell. Thymosin beta-4 binds single actin monomers and holds them in reserve, so it governs how quickly a cell can rebuild its cytoskeleton, crawl and change shape. One peptide probes growth factor and vessel signalling, the other probes cell movement, and a design with both can ask whether the two routes add together.
Recovery stack research: what the studies show
Most of the BPC-157 literature comes from rodent models and cell culture. Tendon work came first: the Journal of Applied Physiology carried a 2011 study of fibroblast outgrowth, survival and migration from rat tendon explants, and the Journal of Molecular Medicine followed in 2017 by tying new vessel growth to VEGFR2. Thymosin beta-4 has a longer biochemical history: a 1991 report in the Journal of Biological Chemistry identified it as the principal actin-sequestering peptide in cells, and a 2004 study in Nature tied it to integrin-linked kinase and to migration of heart cells. Controlled human data for either compound remain very limited. Summaries sit in the BPC-157 research studies and TB-500 research studies libraries.
Recovery stack vial specifications from Australian stock
| Specification | Detail |
|---|---|
| Kit | Recovery stack BPC-157 + TB-500 |
| Amount | stack |
| Form | Research kit |
| Contents | BPC-157 and TB-500 in separate vials |
| Category | Kits, stacks and value packs |
| Storage | See label |
Both vials are crimp-sealed glass with a rubber septum, packed upright in one carton, and the dry cake in each is white. Because the vials come from separate lots, quote each lot code when requesting certificates; the two documents will not share a batch number. Hold the sealed pair at minus 20 °C away from light until reconstitution day.
Recovery stack price against buying the vials separately
| Option | Price |
|---|---|
| Recovery stack BPC-157 + TB-500 | $220.99 |
The stack is priced in line with a BPC-157 10mg vial and a TB-500 10mg vial bought on their own, so its value is one line item with matched labels and one parcel rather than a discount. Labs chasing a lower cost per milligram for the gastric peptide can compare the BPC-157 value pack of three 10mg vials. For work that always uses both at a fixed one to one ratio, the BPC-157 and TB-500 blend holds 5mg of each co-lyophilised in a single vial and needs only one reconstitution.
BPC-157 10mg vial in the recovery stack
The first vial holds 10 milligrams, the same fill as the BPC-157 vial sold singly, so volume sheets written for the single carry straight across. Add 2 mL of bacteriostatic water and the vial reads 5 mg per mL; stretch that to 5 mL and it reads 2 mg per mL, handy when a protocol calls for finer volumes.
TB-500 10mg vial in the recovery stack
The second vial also holds 10 milligrams and matches the TB-500 listing. Kept apart, it can be made up to a different concentration from its partner, left sealed in the freezer while the first vial is in use, or withheld entirely from a control arm. None of that is possible once two peptides share a cake.
Where to buy the recovery stack in Australia
- Sold online at macropuspeptides.com, priced at $220.99
- Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
- A certificate of analysis for every lot, matched to the lot number printed on the label
- Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
- Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
- Payment by PayID or bank transfer, with your order ID as the reference
How to order the recovery stack online
- Open the recovery stack listing
- Add the stack to your cart
- Add a 10mL bacteriostatic water vial
- Confirm research use at checkout
- Record both lot codes on arrival
Recovery stack bac water maths
No diluent ships in the carton, so add bacteriostatic water 10mL to the order. Work out each vial on its own by dividing its label milligrams by the millilitres added. One millilitre turns either 10mg vial into a 10 mg per mL stock; two millilitres halve that to 5; five millilitres bring it down to 2. At two millilitres apiece the pair uses four of the ten in the water vial, leaving six for a later preparation. Run the water slowly down the glass wall and swirl rather than shake, then date each vial, park both solutions in the fridge between 2 and 8 °C, and do not return either to the freezer.
Is the recovery stack legal in Australia
Yes, as research material. BPC-157 and TB-500 are both absent from the ARTG, and the TGA has approved neither as a medicine, which confines the recovery pair to in-vitro bench work with no human or veterinary use. Research peptides are scheduled through the Poisons Standard; a buying lab should read the current entries against its own licences first.
Recovery stack for sale Australia wide
Stacks are packed and dispatched from Australian stock, with no customs hold or international leg. Parcels travel to research groups in Brisbane, Melbourne and Perth, to Adelaide and Hobart, to Darwin and Canberra, and to regional addresses. Related options are the BPC-157 starter kit with water, syringes and swabs, the BPC-157 TB-500 starter kit built on the blend, the single vials in our recovery research range and further combinations under kits and stacks.
References
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011.
- Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine. 2017.
- Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. Journal of Biological Chemistry. 1991.
- Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.